Specifically, there are multiple genetic abnormalities involved in the activation of the Wnt/β-catenin pathway; nonetheless, CTNNB1 mutation is a typical driver mutation that is found in approximately 30% of HCC cases [18]. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.